Skip to content
OpenCapital
Get started

Becton, Dickinson and Company BDX Cash & Equivalents

Cash & Equivalents at other companies

Abbott logo
AbbottABT
$6.8B+4.1%
Baxter International logo
Baxter InternationalBAX
$2.02B-12.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$509M-2.7%
TFX
TeleflexTFX
$329.55M+16.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.28B-21.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$521.4M+29.0%

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M—
CapEx$125.0M+9.6%
Free cash flow$546.0M—

Valuation

See full
Market cap$42.96B-12.6%
Enterprise value$56.65B-14.0%
P/E37.8×+6.7×
P/S2×-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%—

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's cash & equivalents?
Becton, Dickinson and Company (BDX) reported cash & equivalents of $1.02B in Q1 2026.
How has Becton, Dickinson and Company's cash & equivalents changed year-over-year?
Becton, Dickinson and Company's cash & equivalents increased by 49.0% year-over-year, from $681M to $1.02B.
What is the long-term trend for Becton, Dickinson and Company's cash & equivalents?
Over 5 years (2020 to 2025), Becton, Dickinson and Company's cash & equivalents has grown at a -23.2% compound annual growth rate (CAGR), from $2.92B to $777M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.